Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase

Overview of attention for article published in American Journal of Human Genetics, August 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 6 X users
patent: 5 patents

f1000: 1 research highlight platform

Readers on

mendeley: 66 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 5 patents that reference this research output.

Methods for the treatment of trinucleotide repeat expansion disorders associated with…

Grant US-12485136-B2

United States of America

02 Dec 2025

Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated…

Grant US-12297432-B2

United States of America

13 May 2025

Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated…

Grant US-11408000-B2

United States of America

09 Aug 2022

RRM2B AS A THERAPEUTIC TARGET IN THE TREATMENT OF ALZHEIMER'S DISEASE

Application WO-2020070367-A3

World Intellectual Property Organisation (WIPO)

11 Jun 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.